×
Jul 4, 2023 · Pioglitazone is an oral antidiabetic from the thiazolidinedione drug class, FDA approved for treating type 2 diabetes mellitus in adults, as an ...
Missing: license | Show results with:license
People also ask
Active Ingredient: pioglitazone hydrochloride. Inactive Ingredients: lactose monohydrate, hydroxypropylcellulose, carboxymethylcellulose calcium, and magnesium ...
Mar 18, 2024 · Limited data with pioglitazone hydrochloride ... pioglitazone hydrochloride showed that pioglitazone ... “Licensed-United States Patent Nos.
Pioglitazone, sold under the brand name Actos among others, is an anti-diabetic medication used to treat type 2 diabetes. It may be used with metformin, ...
DESCRIPTION. ACTOS (pioglitazone hydrochloride) is an oral antidiabetic agent that acts primarily by decreasing insulin resistance.
Missing: license | Show results with:license
Pioglitazone is an oral antidiabetic agent belonging to the drug class known as the thiazolidinediones (TZD) or "insulin sensitizers".
WARNING: CONGESTIVE HEART FAILURE AND LACTIC ACIDOSIS. See full prescribing information for complete boxed warning. Congestive Heart Failure.
It has recently been licensed in the US for use as monotherapy and in combination with insulin, metformin and sulphonylureas. Its European license is more ...
Use or redistribution of any DrugBank content or data requires a license and proper citations. Talk to sales for commercial licensing. Apply for an academic ...
Technical Data for Pioglitazone hydrochloride. M. Wt, 392.9. Formula, C19H20N2O3S.HCl. Storage, Desiccate at RT. Purity, ≥99% (HPLC). CAS Number, 112529-15-4.